Alkermes Phase II Vivitrex data

ALKS said that in a 30-patient U.S. and European double-blind, placebo-controlled Phase II trial, the 25 alcohol-dependent patients receiving its Vivitrex medisorb naltrexone plus psychosocial therapy...